[HTML][HTML] Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis
Objectives Despite excessive resistance of Helicobacter pylori to clarithromycin among the
Iranian population, clarithromycin-based therapy is still prescribed in Iran. Recent studies …
Iranian population, clarithromycin-based therapy is still prescribed in Iran. Recent studies …
Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis
M Keikha, P Askari, K Ghazvini… - Journal of global …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives Despite excessive resistance of Helicobacter pylori to clarithromycin among the
Iranian population, clarithromycin-based therapy is still prescribed in Iran. Recent studies …
Iranian population, clarithromycin-based therapy is still prescribed in Iran. Recent studies …
[PDF][PDF] Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis
M Keikha, P Askari, K Ghazvini, M Karbalaei - 2021 - scirp.org
abstract Objectives: Despite excessive resistance of Helicobacter pylori to clarithromycin
among the Iranian population, clarithromycin-based therapy is still prescribed in Iran. Recent …
among the Iranian population, clarithromycin-based therapy is still prescribed in Iran. Recent …
Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis.
M Keikha, P Askari, K Ghazvini… - Journal of Global …, 2021 - europepmc.org
Objectives Despite excessive resistance of Helicobacter pylori to clarithromycin among the
Iranian population, clarithromycin-based therapy is still prescribed in Iran. Recent studies …
Iranian population, clarithromycin-based therapy is still prescribed in Iran. Recent studies …
Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis
M Keikha, P Askari, K Ghazvini, M Karbalaei - 2022 - agris.fao.org
Objectives: Despite excessive resistance of Helicobacter pylori to clarithromycin among the
Iranian population, clarithromycin-based therapy is still prescribed in Iran. Recent studies …
Iranian population, clarithromycin-based therapy is still prescribed in Iran. Recent studies …